ECM1 and breast cancer: ECM1 promotes a Warburg effect-like metabolic phenotype (Lee, Nam, Oh, Lim, Lee, et al. 2015), cell proliferation, and trastuzumab resistance (Lee et al. 2014) by the activation of the EGFR pathway in breast cancers.